{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:54:06Z","timestamp":1792079646274,"version":"4.4.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI156100"],"award-info":[{"award-number":["R21AI156100"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R33AI140823"],"award-info":[{"award-number":["R33AI140823"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biofilm"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bioflm.2023.100126","type":"journal-article","created":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T20:03:53Z","timestamp":1682280233000},"page":"100126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Antifungal therapy of Candida biofilms: Past, present and future"],"prefix":"10.1016","volume":"5","author":[{"given":"Olabayo H.","family":"Ajetunmobi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Badali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus A.","family":"Romo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Ramage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1992-3270","authenticated-orcid":false,"given":"Jose L.","family":"Lopez-Ribot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"165","key":"10.1016\/j.bioflm.2023.100126_bib1","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.bioflm.2023.100126_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.chest.2021.08.081","article-title":"Risk factors for invasive Candida infection in critically ill patients: a systematic review and meta-analysis","volume":"161","author":"Thomas-Ruddel","year":"2022","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.bioflm.2023.100126_bib3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/14787210.2020.1750368","article-title":"Multidrug-resistant Candida auris: an epidemiological review","volume":"18","author":"Chakrabarti","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"10.1016\/j.bioflm.2023.100126_bib4","article-title":"Candida auris: a decade of understanding of an enigmatic pathogenic yeast","volume":"6","author":"Kean","year":"2020","journal-title":"J Fungi (Basel)."},{"issue":"2","key":"10.1016\/j.bioflm.2023.100126_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","article-title":"Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance","volume":"36","author":"Silva","year":"2012","journal-title":"FEMS Microbiol Rev"},{"issue":"10","key":"10.1016\/j.bioflm.2023.100126_bib6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.cmi.2019.04.024","article-title":"Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis","volume":"25","author":"Koehler","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.bioflm.2023.100126_bib7","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1093\/cid\/ciaa193","article-title":"Burden of candidemia in the United States, 2017","volume":"71","author":"Tsay","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.bioflm.2023.100126_bib8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2217\/fmb.12.48","article-title":"Candida species: new insights into biofilm formation","volume":"7","author":"Cuellar-Cruz","year":"2012","journal-title":"Future Microbiol"},{"key":"10.1016\/j.bioflm.2023.100126_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2019.04.001","article-title":"Candida albicans biofilm growth and dispersal: contributions to pathogenesis","volume":"52","author":"Wall","year":"2019","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"10.1016\/j.bioflm.2023.100126_bib10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/EC.4.4.633-638.2005","article-title":"Candida biofilms: an update","volume":"4","author":"Ramage","year":"2005","journal-title":"Eukaryot Cell"},{"issue":"18","key":"10.1016\/j.bioflm.2023.100126_bib11","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1128\/JB.183.18.5385-5394.2001","article-title":"Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance","volume":"183","author":"Chandra","year":"2001","journal-title":"J Bacteriol"},{"issue":"5","key":"10.1016\/j.bioflm.2023.100126_bib12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.micinf.2016.01.002","article-title":"Candida albicans biofilms: development, regulation, and molecular mechanisms","volume":"18","author":"Gulati","year":"2016","journal-title":"Microb Infect"},{"issue":"2","key":"10.1016\/j.bioflm.2023.100126_bib13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3201\/eid2302.161320","article-title":"Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris","volume":"23","author":"Sherry","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.bioflm.2023.100126_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01338-18","article-title":"Candida albicans dispersed cells are developmentally distinct from biofilm and planktonic cells","volume":"9","author":"Uppuluri","year":"2018","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.bioflm.2023.100126_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000828","article-title":"Dispersion as an important step in the Candida albicans biofilm developmental cycle","volume":"6","author":"Uppuluri","year":"2010","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.bioflm.2023.100126_bib16","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/j.1462-5822.2006.00761.x","article-title":"Genetics and genomics of Candida albicans biofilm formation","volume":"8","author":"Nobile","year":"2006","journal-title":"Cell Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.bioflm.2023.100126_bib17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2011.10.048","article-title":"A recently evolved transcriptional network controls biofilm development in Candida albicans","volume":"148","author":"Nobile","year":"2012","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bioflm.2023.100126_bib18","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1371\/journal.ppat.0020063","article-title":"Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo","volume":"2","author":"Nobile","year":"2006","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.bioflm.2023.100126_bib19","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/mmi.13002","article-title":"An expanded regulatory network temporally controls Candida albicans biofilm formation","volume":"96","author":"Fox","year":"2015","journal-title":"Mol Microbiol"},{"issue":"11","key":"10.1016\/j.bioflm.2023.100126_bib20","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1128\/AEM.68.11.5459-5463.2002","article-title":"Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule","volume":"68","author":"Ramage","year":"2002","journal-title":"Appl Environ Microbiol"},{"issue":"5","key":"10.1016\/j.bioflm.2023.100126_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.coph.2013.08.008","article-title":"Antifungal therapy with an emphasis on biofilms","volume":"13","author":"Pierce","year":"2013","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"10.1016\/j.bioflm.2023.100126_bib22","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/AAC.45.9.2475-2479.2001","article-title":"Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms","volume":"45","author":"Ramage","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.bioflm.2023.100126_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","article-title":"Antifungal agents: mechanisms of action","volume":"11","author":"Odds","year":"2003","journal-title":"Trends Microbiol"},{"issue":"9","key":"10.1016\/j.bioflm.2023.100126_bib24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrd3074","article-title":"An insight into the antifungal pipeline: selected new molecules and beyond","volume":"9","author":"Ostrosky-Zeichner","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.bioflm.2023.100126_bib25","article-title":"Current antimycotics, new prospects, and future approaches to antifungal therapy","volume":"9","author":"Wall","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.bioflm.2023.100126_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2022.102237","article-title":"Antifungal drug-resistance mechanisms in Candida biofilms","volume":"71","author":"Kaur","year":"2023","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.bioflm.2023.100126_bib27","article-title":"Fungal biofilm resistance","volume":"2012","author":"Ramage","year":"2012","journal-title":"Internet J Microbiol"},{"issue":"10","key":"10.1016\/j.bioflm.2023.100126_bib28","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2217\/fmb.13.101","article-title":"Mechanisms of Candida biofilm drug resistance","volume":"8","author":"Taff","year":"2013","journal-title":"Future Microbiol"},{"issue":"7","key":"10.1016\/j.bioflm.2023.100126_bib29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1567-1364.2006.00117.x","article-title":"Candida biofilms on implanted biomaterials: a clinically significant problem","volume":"6","author":"Ramage","year":"2006","journal-title":"FEMS Yeast Res"},{"issue":"6","key":"10.1016\/j.bioflm.2023.100126_bib30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jac\/dkf045","article-title":"Echinocandins: a new class of antifungal","volume":"49","author":"Denning","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.bioflm.2023.100126_bib31","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1517\/14656566.4.5.807","article-title":"Caspofungin: first approved agent in a new class of antifungals","volume":"4","author":"Johnson","year":"2003","journal-title":"Expet Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.bioflm.2023.100126_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nchembio.1496","article-title":"Amphotericin forms an extramembranous and fungicidal sterol sponge","volume":"10","author":"Anderson","year":"2014","journal-title":"Nat Chem Biol"},{"issue":"7","key":"10.1016\/j.bioflm.2023.100126_bib33","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1073\/pnas.1117280109","article-title":"Amphotericin primarily kills yeast by simply binding ergosterol","volume":"109","author":"Gray","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.bioflm.2023.100126_bib34","first-page":"186","article-title":"Candida biofilms: antifungal resistance and emerging therapeutic options","volume":"5","author":"Kuhn","year":"2004","journal-title":"Curr Opin Invest Drugs"},{"issue":"9","key":"10.1016\/j.bioflm.2023.100126_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The antifungal pipeline: a reality check","volume":"16","author":"Perfect","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.bioflm.2023.100126_bib36","article-title":"Pharmacodynamics, mechanisms of action and resistance, and spectrum of activity of new antifungal agents","volume":"8","author":"Wiederhold","year":"2022","journal-title":"J Fungi (Basel)."},{"issue":"11","key":"10.1016\/j.bioflm.2023.100126_bib37","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1128\/AAC.46.11.3591-3596.2002","article-title":"In vitro activity of caspofungin against Candida albicans biofilms","volume":"46","author":"Bachmann","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.bioflm.2023.100126_bib38","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1128\/AAC.03065-15","article-title":"Biofilm production and antibiofilm activity of echinocandins and liposomal amphotericin B in echinocandin-resistant yeast species","volume":"60","author":"Marcos-Zambrano","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"15","key":"10.1016\/j.bioflm.2023.100126_bib39","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.bioflm.2023.100126_bib40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijantimicag.2017.09.002","article-title":"The antifungal arsenal: alternative drugs and future targets","volume":"51","author":"Wiederhold","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"10.1016\/j.bioflm.2023.100126_bib41","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/cmi.12640","article-title":"CD101: a novel long-acting echinocandin","volume":"18","author":"Zhao","year":"2016","journal-title":"Cell Microbiol"},{"issue":"2","key":"10.1016\/j.bioflm.2023.100126_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01750-17","article-title":"CD101, a novel echinocandin, possesses potent antibiofilm activity against early and mature Candida albicans biofilms","volume":"62","author":"Chandra","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.bioflm.2023.100126_bib43","article-title":"Ibrexafungerp: a first-in-class oral triterpenoid glucan synthase inhibitor","volume":"7","author":"Jallow","year":"2021","journal-title":"J Fungi (Basel)."},{"issue":"7","key":"10.1016\/j.bioflm.2023.100126_bib44","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/jac\/dkx010","article-title":"The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp","volume":"72","author":"Marcos-Zambrano","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.bioflm.2023.100126_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02396-16","article-title":"The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation","volume":"61","author":"Larkin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.bioflm.2023.100126_bib46","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1093\/jac\/dky302","article-title":"Activity of novel antifungal compound APX001A against a large collection of Candida auris","volume":"73","author":"Berkow","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.bioflm.2023.100126_bib47","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1128\/AAC.00731-11","article-title":"E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis","volume":"56","author":"Watanabe","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.bioflm.2023.100126_bib48","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1128\/AAC.00349-16","article-title":"The investigational drug VT-1129 is a highly potent inhibitor of cryptococcus species CYP51 but only weakly inhibits the human enzyme","volume":"60","author":"Warrilow","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2023.100126_bib49","article-title":"Estimating the cost of industry investment in drug research and development: a review of methods and results","volume":"58","author":"Rennane","year":"2021","journal-title":"Inquiry"},{"issue":"7","key":"10.1016\/j.bioflm.2023.100126_bib50","doi-asserted-by":"crossref","first-page":"300","DOI":"10.15698\/mic2018.07.638","article-title":"Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms","volume":"5","author":"Van Dijck","year":"2018","journal-title":"Microb Cell"},{"key":"10.1016\/j.bioflm.2023.100126_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/npjbiofilms.2015.12","article-title":"A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance","volume":"1","author":"Pierce","year":"2015","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"6","key":"10.1016\/j.bioflm.2023.100126_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01991-17","article-title":"Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of Candida albicans filamentation","volume":"8","author":"Romo","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.bioflm.2023.100126_bib53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fcimb.2018.00227","article-title":"In vitro characterization of a biaryl amide anti-virulence compound targeting Candida albicans filamentation and biofilm formation","volume":"8","author":"Romo","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.bioflm.2023.100126_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00620-19","article-title":"Global transcriptomic analysis of the Candida albicans response to treatment with a novel inhibitor of filamentation","volume":"4","author":"Romo","year":"2019","journal-title":"mSphere"},{"issue":"4","key":"10.1016\/j.bioflm.2023.100126_bib55","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/jac\/dkq530","article-title":"Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms","volume":"66","author":"LaFleur","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.bioflm.2023.100126_bib56","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/AAC.04229-14","article-title":"Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms","volume":"59","author":"De Cremer","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"6519","key":"10.1016\/j.bioflm.2023.100126_bib57","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.abd6919","article-title":"A marine microbiome antifungal targets urgent-threat drug-resistant fungi","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bioflm.2023.100126_bib58","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145123","article-title":"Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking","volume":"131","author":"Zhao","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.bioflm.2023.100126_bib59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1128\/IAI.00914-12","article-title":"Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans","volume":"81","author":"Cruz","year":"2013","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.bioflm.2023.100126_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01334-19","article-title":"Antifungal activity of the Enterococcus faecalis peptide EntV requires protease cleavage and disulfide bond formation","volume":"10","author":"Brown","year":"2019","journal-title":"mBio"},{"issue":"17","key":"10.1016\/j.bioflm.2023.100126_bib61","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1073\/pnas.1620432114","article-title":"Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans","volume":"114","author":"Graham","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.bioflm.2023.100126_bib62","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1038\/s41467-022-33613-1","article-title":"Structural and functional analysis of EntV reveals a 12 amino acid fragment protective against fungal infections","volume":"13","author":"Cruz","year":"2022","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.bioflm.2023.100126_bib63","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.bioflm.2023.100126_bib64","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1208\/s12248-012-9390-1","article-title":"Drug repurposing: far beyond new targets for old drugs","volume":"14","author":"Oprea","year":"2012","journal-title":"AAPS J"},{"issue":"9","key":"10.1016\/j.bioflm.2023.100126_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002870","article-title":"Antifungal drug discovery: something old and something new","volume":"8","author":"Butts","year":"2012","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.1016\/j.bioflm.2023.100126_bib66","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.drudis.2022.04.021","article-title":"Repurposing and optimization of drugs for discovery of novel antifungals","volume":"27","author":"Donlin","year":"2022","journal-title":"Drug Discov Today"},{"issue":"8","key":"10.1016\/j.bioflm.2023.100126_bib67","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/myc.13477","article-title":"Drug repurposing against Candida auris: a systematic review","volume":"65","author":"Izadi","year":"2022","journal-title":"Mycoses"},{"issue":"9","key":"10.1016\/j.bioflm.2023.100126_bib68","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00924-20","article-title":"Screening repurposing libraries for identification of drugs with novel antifungal activity","volume":"64","author":"Wall","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.bioflm.2023.100126_bib69","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01084-18","article-title":"Screening a repurposing library for inhibitors of multidrug-resistant Candida auris identifies ebselen as a repositionable candidate for antifungal drug development","volume":"62","author":"Wall","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.bioflm.2023.100126_bib70","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/apm.13260","article-title":"Screening the Tocriscreen bioactive compound library in search for inhibitors of Candida biofilm formation","volume":"130","author":"Abduljalil","year":"2022","journal-title":"APMIS"},{"issue":"5","key":"10.1016\/j.bioflm.2023.100126_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00539-18","article-title":"Alexidine dihydrochloride has broad-spectrum activities against diverse fungal pathogens","volume":"3","author":"Mamouei","year":"2018","journal-title":"mSphere"},{"issue":"8","key":"10.1016\/j.bioflm.2023.100126_bib72","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1128\/AAC.00680-13","article-title":"High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors","volume":"57","author":"Siles","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.bioflm.2023.100126_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001762","article-title":"Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis","volume":"20","author":"Sutar","year":"2022","journal-title":"PLoS Biol"},{"issue":"2","key":"10.1016\/j.bioflm.2023.100126_bib74","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/21505594.2016.1196301","article-title":"Repurposing auranofin as an antifungal: in vitro activity against a variety of medically important fungi","volume":"8","author":"Wiederhold","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.bioflm.2023.100126_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.813973","article-title":"Recent developments on using nanomaterials to combat Candida albicans","volume":"9","author":"Li","year":"2021","journal-title":"Front Chem"},{"key":"10.1016\/j.bioflm.2023.100126_bib76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12951-015-0147-8","article-title":"Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study","volume":"13","author":"Lara","year":"2015","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"10.1016\/j.bioflm.2023.100126_bib77","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/08927014.2011.599101","article-title":"Silver colloidal nanoparticles: antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrata","volume":"27","author":"Monteiro","year":"2011","journal-title":"Biofouling"},{"issue":"19","key":"10.1016\/j.bioflm.2023.100126_bib78","doi-asserted-by":"crossref","first-page":"21183","DOI":"10.1021\/acsami.9b20708","article-title":"Inhibition of Candida auris biofilm formation on medical and environmental surfaces by silver nanoparticles","volume":"12","author":"Lara","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.bioflm.2023.100126_bib79","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.3389\/fmicb.2020.01673","article-title":"Silver nanoantibiotics display strong antifungal activity against the emergent multidrug-resistant yeast Candida auris under both planktonic and biofilm growing conditions","volume":"11","author":"Vazquez-Munoz","year":"2020","journal-title":"Front Microbiol"},{"issue":"10","key":"10.1016\/j.bioflm.2023.100126_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108876","article-title":"Ultrastructural analysis of Candida albicans when exposed to silver nanoparticles","volume":"9","author":"Vazquez-Munoz","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bioflm.2023.100126_bib81","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s42490-020-00044-2","article-title":"Bismuth nanoparticles obtained by a facile synthesis method exhibit antimicrobial activity against Staphylococcus aureus and Candida albicans","volume":"2","author":"Vazquez-Munoz","year":"2020","journal-title":"BMC Biomed Eng"},{"key":"10.1016\/j.bioflm.2023.100126_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2020.100894","article-title":"Fast, facile synthesis method for BAL-mediated PVP-bismuth nanoparticles","volume":"7","author":"Vazquez-Munoz","year":"2020","journal-title":"MethodsX"},{"issue":"8","key":"10.1016\/j.bioflm.2023.100126_bib83","article-title":"Bismuth nanoantibiotics display anticandidal activity and disrupt the biofilm and cell morphology of the emergent pathogenic yeast Candida auris","volume":"9","author":"Vazquez-Munoz","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.bioflm.2023.100126_bib84","series-title":"Curcumin nanoparticles: the topical antimycotic suspension treating oral candidiasis","author":"Anwar","year":"2022"},{"key":"10.1016\/j.bioflm.2023.100126_bib85","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2147\/IJN.S151285","article-title":"Synergistic antifungal effect of chitosan-stabilized selenium nanoparticles synthesized by pulsed laser ablation in liquids against Candida albicans biofilms","volume":"13","author":"Lara","year":"2018","journal-title":"Int J Nanomed"},{"issue":"10","key":"10.1016\/j.bioflm.2023.100126_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9100784","article-title":"Inhibition of mixed biofilms of Candida albicans and methicillin-resistant Staphylococcus aureus by positively charged silver nanoparticles and functionalized silicone elastomers","volume":"9","author":"Lara","year":"2020","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.bioflm.2023.100126_bib87","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jobm.201100158","article-title":"Effect of exogenous administration of Candida albicans autoregulatory alcohols in a murine model of hematogenously disseminated candidiasis","volume":"52","author":"Martins","year":"2012","journal-title":"J Basic Microbiol"},{"issue":"1","key":"10.1016\/j.bioflm.2023.100126_bib88","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1439-0507.2011.02047.x","article-title":"Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms","volume":"55","author":"Martins","year":"2012","journal-title":"Mycoses"},{"issue":"10","key":"10.1016\/j.bioflm.2023.100126_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10102091","article-title":"Vaginal lactobacillus impair Candida dimorphic switching and biofilm formation","volume":"10","author":"Parolin","year":"2022","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.bioflm.2023.100126_bib90","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.archoralbio.2009.01.016","article-title":"Sensitivity of Candida albicans biofilm cells grown on denture acrylic to antifungal proteins and chlorhexidine","volume":"54","author":"Pusateri","year":"2009","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.bioflm.2023.100126_bib91","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2217\/fmb-2022-0053","article-title":"Combined antibiofilm activity of synthetic peptides and antifungal drugs against Candida spp","volume":"17","author":"Bezerra","year":"2022","journal-title":"Future Microbiol"},{"issue":"7","key":"10.1016\/j.bioflm.2023.100126_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14071332","article-title":"Combination of six individual derivatives of the pom-1 antibiofilm peptide doubles their efficacy against invasive and multi-resistant clinical isolates of the pathogenic yeast Candida albicans","volume":"14","author":"Haring","year":"2022","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.bioflm.2023.100126_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002257","article-title":"Hsp90 governs dispersion and drug resistance of fungal biofilms","volume":"7","author":"Robbins","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bioflm.2023.100126_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2023.103343","article-title":"Photodynamic inactivation of different Candida species and inhibition of biofilm formation induced by water-soluble porphyrins","volume":"42","author":"Amorim","year":"2023","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"2","key":"10.1016\/j.bioflm.2023.100126_bib95","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2217\/fmb.15.139","article-title":"Management of Candida biofilms: state of knowledge and new options for prevention and eradication","volume":"11","author":"Bujdakova","year":"2016","journal-title":"Future Microbiol"},{"issue":"6","key":"10.1016\/j.bioflm.2023.100126_bib96","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s10103-012-1050-2","article-title":"Photodynamic inactivation of biofilms formed by Candida spp., Trichosporon mucoides, and Kodamaea ohmeri by cationic nanoemulsion of zinc 2,9,16,23-tetrakis(phenylthio)-29H, 31H-phthalocyanine (ZnPc)","volume":"27","author":"Junqueira","year":"2012","journal-title":"Laser Med Sci"},{"issue":"3","key":"10.1016\/j.bioflm.2023.100126_bib97","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10103-010-0852-3","article-title":"Susceptibility of Candida albicans, Staphylococcus aureus, and Streptococcus mutans biofilms to photodynamic inactivation: an in vitro study","volume":"26","author":"Pereira","year":"2011","journal-title":"Laser Med Sci"},{"issue":"1","key":"10.1016\/j.bioflm.2023.100126_bib98","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/dkn160","article-title":"In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth","volume":"62","author":"Cateau","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.bioflm.2023.100126_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics4010001","article-title":"The role of antifungals against Candida biofilm in catheter-related candidemia","volume":"4","author":"Bouza","year":"2014","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.bioflm.2023.100126_bib100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.dental.2020.11.028","article-title":"Persistent inhibition of Candida albicans biofilm and hyphae growth on titanium by graphene nanocoating","volume":"37","author":"Agarwalla","year":"2021","journal-title":"Dent Mater"},{"issue":"1","key":"10.1016\/j.bioflm.2023.100126_bib101","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tim.2016.09.004","article-title":"Portrait of Candida species biofilm regulatory network genes","volume":"25","author":"Araujo","year":"2017","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bioflm.2023.100126_bib102","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01701-10","article-title":"Effect of fluconazole, amphotericin B and caspofungin against Candida albicans biofilms under conditions of flow and on biofilm dispersion","author":"Uppuluri","year":"2011","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Biofilm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207523000230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207523000230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:59:22Z","timestamp":1762919962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590207523000230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":102,"alternative-id":["S2590207523000230"],"URL":"https:\/\/doi.org\/10.1016\/j.bioflm.2023.100126","relation":{},"ISSN":["2590-2075"],"issn-type":[{"value":"2590-2075","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal therapy of Candida biofilms: Past, present and future","name":"articletitle","label":"Article Title"},{"value":"Biofilm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioflm.2023.100126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100126"}}